EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension

Sila Ozlem Sener, Rateep Nasim, Talat Nasim

BioChem · 10.09.2024 · 4 (3) · 236-251

DOI: 10.3390/biochem4030012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioChem, online erschienen am 10.09.2024. Verfasst von Sila Ozlem Sener und 2 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GrowMedtech, Commonwealth Scholarship Commission (CSC), Great Britain Sasakawa Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary arterial hypertension (PAH) is a progressive disorder caused by the narrowing of small blood vessels in the lungs, which, in the absence of therapies, leads to right heart failure and premature death. No cure for this devastating disorder is known. Current management therapies aim to improve symptoms, and hence, there is a need to identify novel therapeutic interventions. The major objectives of this review are to critically evaluate current treatment strategies and highlight the challenges and prospects of established drugs and natural products for the resolution of PAH.

Förderung

  • GrowMedtech
  • Commonwealth Scholarship Commission (CSC)
  • Great Britain Sasakawa Foundation
  • University of Bradford (UoB)
  • TUBITAK

Zitieren

APA

Sener, S. O., Nasim, R., & Nasim, T. (2024). The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension. BioChem, 4(3), 236-251. https://doi.org/10.3390/biochem4030012

Vancouver

Sener SO, Nasim R, Nasim T. The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension. BioChem. 2024;4(3):236-251. doi:10.3390/biochem4030012

BibTeX
@article{Sener2024,
  author = {Sener, Sila Ozlem and Nasim, Rateep and Nasim, Talat},
  title = {The Prospect and Challenges of Repurposing Established Drugs in Pulmonary Arterial Hypertension},
  journal = {BioChem},
  year = {2024},
  volume = {4},
  number = {3},
  pages = {236--251},
  doi = {10.3390/biochem4030012}
}
Kostenlos starten →